36th Annual Meeting and Exposition
of the Controlled Release Society
July 18-22, 2009
Bella Center
Copenhagen, Denmark
Bioactive Materials and Veterinary Mini-Symposia Speakers and Topics
AIDS – Back to Basics
Mario Clerici, Milano University, Italy, New Concepts in the Immunopathogenesis of HIV
Patrick Kiser, University of Utah, U.S.A., Delivery Systems Designed to Prevent HIV Transmission
Virendra Pandey, University of Medicine and Dentistry of New Jersey, U.S.A., Targeting Critical Regions of HIV-1 Genome for Intervention of HIV-1 Replication<
Patrick Sinko, Rutgers University, U.S.A., Active Targeting OF HIV Sanctuary Sites Using Biodegradable Peptide-Based PEG Nanocarriers
Hydrogels - From Nanoparticulate Drug Carriers to Tissue Engineering Scaffold
Innovations in Drug Delivery for Animal and Human Health Applications
Elias Fattal, University of Paris-XI, France, Delivery Systems for the Removal of Colonic Residual Antibiotic to Reduce the Emergence of Resistances
Mathieu Peyrou, Novartis Animal Health, Switzerland, Innovative PK Approaches in the Development of Controlled Release Veterinary Drugs
Michael Roberts, University of Queensland, Australia, Enhancement Strategies in Skin Penetration of Solutes and Nanoparticles: Species Differences
Thierry Vandamme, University of Strasbourg, France, Drug Delivery Systems Developed for Animal Health Applications
Malaria, 1 Million Deaths a Year and Still Counting!
Ann Grobler, North-West University, South Africa
Song Jian-Ping, Guangzhou University of Chinese Medicine, China
Solomon Nwaka, World Health Organization, Switzerland<
Richard Haynes, Hong Kong University, China, Artemisins-Marvellous Antimalrian Drugs-Advantages and Shortcomings
Neurodegeneration – Stopping the Clock
Christian Czech, F. Hoffmann-LaRoche, Switzerland, Disease Modification and New Biomarkers for Alzheimer’s Disease
Paul Gellert, AstraZeneca, U.K., Linking Disease and Delivery
John Hardy, National Institutes of Health, U.S.A., Fundamental Biology: New Therapeutic Opportunities
Samuel Svensson, AstraZeneca, Sweden
Translational Medicine–From the Lab to the Patient
Ruth Duncan, Cardiff University, U.K.
Jeff Evans, University of Glasgow Cancer Research, Scotland, Anti-Cancer Drug Development: Promises and Pitfalls
Tim Higenbottam, Chiesi Farmaceutici SpA, Italy
Alberto Gabizon, Shaare Zedek MC, Israel, Liposome Applications in Cancer Therapy-Doing New Tricks to Old Drugs
Jindrich (Henry) Kopecek, University of Utah, U.S.A., Polymeric Nanomedicines: Current Status and Future Prospects
All speakers, topics, and titles are subject to change.
|